Crohn's Disease

Crohn's disease is a chronic, relapsing inflammatory bowel disease that can affect any part of the gastrointestinal tract from mouth to anus, most often the terminal ileum and colon. Its inflammation is typically transmural and discontinuous, producing characteristic skip lesions, and it tends to follow a progressive course that can lead to strictures, fistulae, and abscesses.

Definition

Crohn's disease is an idiopathic, chronic inflammatory bowel disease characterised by transmural, patchy inflammation that may involve any segment of the gastrointestinal tract and frequently produces strictures and fistulae.

Scope

This entry covers Crohn's disease as a clinical entity: its definition, immunopathogenesis, characteristic pattern of bowel involvement, common complications, epidemiology, and the evidence base summarised in guidelines and reviews. It distinguishes Crohn's disease from ulcerative colitis. It is a reference overview and does not provide individualised diagnostic or treatment recommendations.

Core questions

• What distinguishes the transmural, skip-lesion pattern of Crohn's disease from the continuous mucosal inflammation of ulcerative colitis?
• How do genetic susceptibility, the microbiome, and immune dysregulation combine to drive Crohn's disease?
• Why does Crohn's disease tend to progress toward stricturing and penetrating complications over time?

Key concepts

• Transmural inflammation
• Skip lesions and discontinuous involvement
• Terminal ileal and ileocolonic disease
• Strictures, fistulae, and abscesses
• Non-caseating granulomas
• Genetic susceptibility (including NOD2/CARD15)
• Microbiome and dysbiosis

Mechanisms

Crohn's disease arises from a dysregulated mucosal immune response to gut microbiota in a genetically predisposed host, with impaired innate immunity, defective handling of intracellular bacteria, and a sustained inflammatory response. Variants in genes such as NOD2/CARD15 illustrate the role of bacterial sensing and autophagy in susceptibility. Because the inflammation is transmural, it extends through the full thickness of the bowel wall, which underlies the tendency toward fibrostenotic strictures and penetrating fistulae rather than the mucosa-limited disease seen in ulcerative colitis. Non-caseating granulomas may be present on histology but are not required for diagnosis.

Clinical relevance

Crohn's disease commonly presents with chronic diarrhoea, abdominal pain, weight loss, and fatigue, and may include perianal disease and extra-intestinal manifestations. Recognising its transmural, segmental nature is central to interpreting imaging, endoscopy, and pathology. This entry describes the disease for reference and educational purposes and is not a basis for individual diagnosis or therapy.

Epidemiology

Crohn's disease is most prevalent in North America and Europe, with incidence rising in regions undergoing industrialisation. It typically presents in adolescence or early adulthood, though it can occur at any age, and both genetic and environmental factors, including smoking, influence risk and course.

Evidence & guidelines

Comprehensive narrative reviews (Torres et al., 2017; Abraham & Cho, 2009) summarise pathogenesis and natural history, and consensus guidelines such as those of the British Society of Gastroenterology (Lamb et al., 2019) frame contemporary management principles. This entry conveys orientation rather than prescriptive protocols.

History

The disease bears the name of Burrill Crohn, who with Leon Ginzburg and Gordon Oppenheimer described regional ileitis in 1932, although earlier reports of similar bowel inflammation exist. Over subsequent decades the recognition that the condition could affect the entire gastrointestinal tract, and the elucidation of its genetic and immunological basis, refined the modern concept summarised by later reviews (Torres et al., 2017).

Debates

How sharp is the boundary between Crohn's disease and ulcerative colitis?

A subset of colitis cannot be confidently classified as either entity (inflammatory bowel disease unclassified), and overlapping genetic and immunological features have prompted ongoing discussion about whether the two are distinct diseases or a spectrum.

Key figures

• Burrill Crohn
• Leon Ginzburg
• Gordon Oppenheimer

Seminal works

• torres-2017
• abraham-cho-2009

Frequently asked questions

How does Crohn's disease differ from ulcerative colitis?

Crohn's disease can involve any part of the gastrointestinal tract with transmural, discontinuous (skip-lesion) inflammation and a tendency to form strictures and fistulae, whereas ulcerative colitis is limited to the colon with continuous, mucosa-confined inflammation starting in the rectum.

Is Crohn's disease curable?

It is a chronic condition managed over the long term rather than cured; this entry is educational and does not provide treatment guidance, which should come from a qualified clinician.